Total Payments
$2,320
2024 Payments
$256.87
Companies
32
Transactions
143
Medicare Patients
798
Medicare Billing
$45,180
Payment Breakdown by Category
Food & Beverage$2,316 (99.8%)
Education$4.22 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,316 | 142 | 99.8% |
| Education | $4.22 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $262.87 | 10 | $0 (2024) |
| ABBVIE INC. | $251.54 | 17 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $211.37 | 12 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $187.36 | 15 | $0 (2024) |
| Amgen Inc. | $167.26 | 11 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $120.78 | 7 | $0 (2024) |
| PFIZER INC. | $117.59 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $116.10 | 7 | $0 (2023) |
| GlaxoSmithKline, LLC. | $111.67 | 7 | $0 (2024) |
| Lilly USA, LLC | $101.42 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $256.87 | 13 | GlaxoSmithKline, LLC. ($48.08) |
| 2023 | $740.88 | 48 | ABBVIE INC. ($151.31) |
| 2022 | $1,205 | 73 | AstraZeneca Pharmaceuticals LP ($180.76) |
| 2021 | $117.52 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($28.05) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Immunology | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Bone Health | ||||||
| 03/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: PAIN | ||||||
| 02/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Gastroenterology | ||||||
| 01/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: PAIN | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Obesity | ||||||
| 01/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardio-renal | ||||||
| 12/13/2023 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Obesity | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Bone Health | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Respiratory | ||||||
| 11/21/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: VACCINES | ||||||
| 11/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 12 | 798 | 2,004 | $121,785 | $45,180 |
Total Patients
798
Total Services
2,004
Medicare Billing
$45,180
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 424 | 635 | $92,075 | $36,919 | 40.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 40 | $3,800 | $1,727 | 45.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 71 | 1,009 | $10,090 | $1,075 | 10.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 41 | 56 | $1,680 | $948.30 | 56.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $2,450 | $901.61 | 36.8% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 44 | 64 | $928.00 | $776.05 | 83.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 73 | 91 | $2,275 | $723.59 | 31.8% |
| 94729 | Measurement of lung diffusing capacity | Office | 2020 | 19 | 19 | $2,125 | $596.20 | 28.1% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2020 | 19 | 19 | $1,572 | $590.63 | 37.6% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 29 | 29 | $2,900 | $539.84 | 18.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2020 | 13 | 13 | $1,625 | $244.90 | 15.1% |
| 99421 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 5-10 minutes | Office | 2020 | 15 | 15 | $264.75 | $137.20 | 51.8% |
About Catherine Marshall, APRN
Catherine Marshall, APRN is a Community Health Worker healthcare provider based in Spartanburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1386893121.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Catherine Marshall, APRN has received a total of $2,320 in payments from pharmaceutical and medical device companies, with $256.87 received in 2024. These payments were reported across 143 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,316).
As a Medicare-enrolled provider, Marshall has provided services to 798 Medicare beneficiaries, totaling 2,004 services with total Medicare billing of $45,180. Data is available for 1 year (2020–2020), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Community Health Worker
- Other Specialties Nurse Practitioner
- Location Spartanburg, SC
- Active Since 09/17/2008
- Last Updated 05/02/2025
- Taxonomy Code 172V00000X
- Entity Type Individual
- NPI Number 1386893121
Products in Payments
- VRAYLAR (Drug) $205.94
- TRINTELLIX (Drug) $195.41
- Kerendia (Drug) $187.36
- BREZTRI (Drug) $167.51
- XIFAXAN (Drug) $120.78
- LEQVIO (Drug) $98.33
- TRELEGY ELLIPTA (Drug) $83.06
- NURTEC ODT (Drug) $81.08
- Otezla (Drug) $75.20
- Vascepa (Drug) $71.33
- EVENITY (Biological) $67.66
- INJECTAFER (Drug) $66.74
- TRULICITY (Drug) $53.15
- FARXIGA (Drug) $52.07
- NOCDURNA (Drug) $51.56
- SOLIQUA 100/33 (Biological) $51.42
- DUPIXENT (Biological) $42.59
- PREVNAR 20 (Biological) $40.46
- XYOSTED (Drug) $38.39
- Azstarys (Drug) $29.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.